alpha-Hydroxylinoleic acid

DB16027InvestigationalSmall molecule

alpha-Hydroxylinoleic acid is under investigation in clinical trial NCT04431258 (ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study).

Formula / weight: C₁₈H₃₂O₃ · 296.451 g/mol (avg)
Also known as: .ALPHA.-HYDROXYLINOLEIC ACID · (9Z,12Z)-2-HYDROXY-9,12-OCTADECADIENOIC ACID · 9,12-OCTADECADIENOIC ACID, 2-HYDROXY-, (9Z,12Z)-
Code names: ABTL-0812

Resolves to

Compound

UNII0DE74TJ7EZCAS57818-44-7ChEBI136927

Structure

InChIKeyAFDSETGKYZMEEA-HZJYTTRNSA-NSMILESCCCCC\C=C/C\C=C/CCCCCCC(O)C(O)=O

Targets

Q07869PPARAQ03181PPARDP37231PPARG

What you can answer from here — as of August 30, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with alpha-Hydroxylinoleic acid, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account